TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2024 Jun 25

PMID 38918306

Authors

Chunxiang Yu

Juan Wang

Yan Li

Affiliations

Soon will be listed here.

Abstract

Cervical cancer (CC) is a malignant tumor primarily caused by the persistent infection with high-risk strains of human papillomavirus. This study investigates the aberrant expression of Tripartite Motif Containing 8 (TRIM8) in CC and its impact on cell proliferation, invasion, and migration. Expression levels of TRIM8, Proliferating Cell Nuclear Antigen, and Suppressor of Cytokine Signaling 1 (SOCS1) were assessed in CC cell lines. CC cells were transfected with si-TRIM8, followed by cell counting kit-8 (CCK-8) assay, colony formation assay, and Transwell assay. Protein immunoprecipitation assay was employed to examine TRIM8's binding with SOCS1, and the ubiquitination level of SOCS1 was determined after MG132 treatment. Rescue experiments were conducted using si-SOCS1 and si-TRIM8 in combination. Results indicate upregulation of TRIM8 in CC cells. Inhibition of TRIM8 suppressed cell viability, proliferation, invasion, and migration. TRIM8 promoted CC cell proliferation, invasion, and migration of CC cells through ubiquitination-mediated degradation of SOCS1. Inhibition of SOCS1 partially reversed the inhibitory effects of si-TRIM8 on the proliferation, invasion, and migration of CC cells. In conclusion, TRIM8 enhances CC cell proliferation, invasion, and migration via ubiquitination-mediated degradation of SOCS1.

Citing Articles

Multifaceted role of in health and disease.

Maghsoudloo M, Mokhtari K, Jamali B, Gholamzad A, Entezari M, Hashemi M MedComm (2020). 2024; 5(11):e790.

PMID: 39534556 PMC: 11554878. DOI: 10.1002/mco2.790.

References

Balasubramaniam S, Balakrishnan V, Oon C, Kaur G . Key Molecular Events in Cervical Cancer Development. Medicina (Kaunas). 2019; 55(7). PMC: 6681523. DOI: 10.3390/medicina55070384. View

Beaurivage C, Champagne A, Tobelaim W, Pomerleau V, Menendez A, Saucier C . SOCS1 in cancer: An oncogene and a tumor suppressor. Cytokine. 2016; 82:87-94. DOI: 10.1016/j.cyto.2016.01.005. View

Berzaghi R, Maia V, Pereira F, Melo F, Guedes M, Origassa C . SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression. Sci Rep. 2017; 7:40585. PMC: 5227698. DOI: 10.1038/srep40585. View

Bhaduri U, Merla G . Rise of TRIM8: A Molecule of Duality. Mol Ther Nucleic Acids. 2020; 22:434-444. PMC: 7533350. DOI: 10.1016/j.omtn.2020.08.034. View

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

Caratozzolo M, Marzano F, Mastropasqua F, Sbisa E, Tullo A . TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role. Genes (Basel). 2017; 8(12). PMC: 5748672. DOI: 10.3390/genes8120354. View

Chen Q, Yin D, Zhang Y, Yu L, Li X, Zhou Z . MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis. Cell Death Dis. 2017; 8(6):e2906. PMC: 5520877. DOI: 10.1038/cddis.2017.142. View

Cockram P, Kist M, Prakash S, Chen S, Wertz I, Vucic D . Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021; 28(2):591-605. PMC: 7798376. DOI: 10.1038/s41418-020-00708-5. View

Cohen P, Jhingran A, Oaknin A, Denny L . Cervical cancer. Lancet. 2019; 393(10167):169-182. DOI: 10.1016/S0140-6736(18)32470-X. View

10.

Esposito J, De Iuliis V, Avolio F, Liberatoscioli E, Pulcini R, Di Francesco S . Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis. Cancers (Basel). 2022; 14(9). PMC: 9099786. DOI: 10.3390/cancers14092309. View

11.

Gong H, Tao Y, Mao X, Song D, You D, Ni J . MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway through negatively targeting DNMT3B. Int J Mol Med. 2019; 44(4):1219-1232. PMC: 6713425. DOI: 10.3892/ijmm.2019.4287. View

12.

Gong Y, Wan J, Zou W, Lian G, Qin J, Wang Q . MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1. Future Oncol. 2019; 15(15):1729-1744. DOI: 10.2217/fon-2018-0497. View

13.

Guo L, Dong W, Fu X, Lin J, Dong Z, Tan X . Tripartite Motif 8 (TRIM8) Positively Regulates Pro-inflammatory Responses in Pseudomonas aeruginosa-Induced Keratitis Through Promoting K63-Linked Polyubiquitination of TAK1 Protein. Inflammation. 2016; 40(2):454-463. DOI: 10.1007/s10753-016-0491-3. View

14.

Hill E . Updates in Cervical Cancer Treatment. Clin Obstet Gynecol. 2019; 63(1):3-11. DOI: 10.1097/GRF.0000000000000507. View

15.

Ilangumaran S, Bobbala D, Ramanathan S . SOCS1: Regulator of T Cells in Autoimmunity and Cancer. Curr Top Microbiol Immunol. 2017; 410:159-189. DOI: 10.1007/82_2017_63. View

16.

Kim M, Kim M, Kim W, Kang M, Cacalano N, Kang S . Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells. PLoS One. 2015; 10(4):e0123133. PMC: 4388447. DOI: 10.1371/journal.pone.0123133. View

17.

Li Q, Yan J, Mao A, Li C, Ran Y, Shu H . Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci U S A. 2011; 108(48):19341-6. PMC: 3228454. DOI: 10.1073/pnas.1110946108. View

18.

Lin L, Chen S, Wang H, Gao B, Kallakury B, Bhuvaneshwar K . SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma. Theranostics. 2021; 11(9):4232-4250. PMC: 7977457. DOI: 10.7150/thno.49819. View

19.

Liu Y, Zhang B, Shi T, Qin H . miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8. Onco Targets Ther. 2017; 10:1115-1122. PMC: 5338957. DOI: 10.2147/OTT.S110468. View

20.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View